重大事件
即時報告
8-K
2026-07-29
InspireMD裁撤首席商務官職位 業務重組高層離任
AI 繁中摘要
InspireMD（納斯達克代碼：NSPR）於2026年7月29日提交8-K表格，披露管理層人事變動。根據報告，公司已於7月23日通知首席商務官Shane Gleason，其職位被即時裁撤，最後工作日為2026年7月31日。是次變動屬於公司業務重組的一部分，暫未公佈繼任人選或具體過渡安排。投資者宜留意此高層離任對公司商業化策略及短期營運的潛在影響。
展開英文正文
false 0001433607 0001433607 2026-07-23 2026-07-23 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 23, 2026 InspireMD, Inc. (Exact name of registrant as specified in its charter) Delaware 001-35731 26-2123838 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 6303 Waterford District Drive, Suite 215 Miami, Florida 33126 33126 (Address of principal executive offices) (Zip Code) Registrant’s telephone number, including area code: (888) 776-6804 (Former name or former address, if changed since last report.) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.0001 par value per share NSPR The Nasdaq Capital Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On July 23, 2026, InspireMD, Inc. (the “Company”) provided notice to Shane Gleason, the Company’s Chief Commercial Officer, that his position has been eliminated. His last day of employment with the Company will be July 31, 2026. Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INSPIREMD, INC. Date: July 29, 2026 By: /s/ Marvin Slosman Name: Marvin Slosman Title: Chief Executive Officer